Navigation Links
Massachusetts Woman Seriously Injured by Ethicon Transvaginal Mesh Device, Alleges Parker Waichman LLP in Lawsuit
Date:8/29/2013

New York, New York (PRWEB) August 29, 2013

Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by dangerous drugs and defective medical devices, has filed a lawsuit on behalf of a Massachusetts woman who alleges that a transvaginal mesh implant seriously injured her. The suit was filed on June 11, 2013, in the U.S. District Court for the Southern District of West Virginia (Case No. 2:13-cv-14063) in the Multidistrict Litigation (MDL) In Re: Ethicon Inc., Pelvic Repair System Products Liability Litigation, MDL No. 2327. Ethicon, Inc., Ethicon, LLC and Johnson & Johnson have been named as Defendants.

According to the Complaint, the Plaintiff was implanted with the TVT device on June 9, 2009. The implant was supposed to help treat stress urinary incontinence (SUI) and pelvic organ prolapse (POP), conditions caused by the weakening of the pelvic wall. Transvaginal mesh products are designed to help bolster the pelvic wall, as well as treat POP and SUI. The lawsuit, however, alleges that the mesh device was defective and had a flawed design that caused serious, and possibly permanent, injuries. The suit further alleges that the Defendant knew about the dangers of its product but chose not to warn consumers.

Thousands of transvaginal mesh lawsuits have been formulated into six MDLs pending in U.S. District Court for the Southern District of West Virginia. The list is comprised of In Re: Ethicon, Inc., Pelvic Repair Systems Products Liability Litigation, MDL No. 2327; In Re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation, MDL No. 2325; In Re: C.R. Bard, Inc., Pelvic Repair Systems Products Liability Litigation, MDL No. 2187; In Re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation, MDL No. 2326; In Re: Coloplast Corp., Pelvic Support Systems Products Liability Litigation, MDL No. 2387; and In Re Cook Medical, Inc., Pelvic Repair System Products Liability Litigation, MDL No. 2440.

The U.S. Food and Drug Administration (FDA) reported on July 13, 2011, that the most common complications associated with transvaginal mesh may include:

  •     Mesh erosion through the vagina (also called exposure, extrusion, or protrusion)
  •     Pain
  •     Infection
  •     Bleeding
  •     Pain during sexual intercourse (dyspareunia)
  •     Organ perforation
  •     Urinary problems

The FDA also stated that complications linked to transvaginal mesh implants are “not rare” and warned that use of such devices may actually be more harmful compared to alternative methods for treating pelvic organ prolapse (POP).

Parker Waichman LLP continues to offer free lawsuit consultations to victims of transvaginal mesh injuries. If you or a loved one experienced complications following POP and SUI surgery with mesh, please visit the firm's transvaginal mesh injury page at yourlawyer.com. Free case evaluations are also available by calling 1 800 LAW INFO (1-800-529-4636).

Contact:
Parker Waichman LLP
Gary Falkowitz, Managing Attorney
1+ (800) LAW-INFO
1+ (800) 529-4636
http://www.yourlawyer.com

Read the full story at http://www.prweb.com/releases/TVM_ethicon_blake/08/prweb11076277.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. 21st Century Oncology Renews Research Commitment with Massachusetts General Hospital
2. Middleman Productions Announces that Provocative "Staying Grounded" Exhibit Finds Its Wings in Locations Around Massachusetts
3. Employment Lawyers at Gilman Law LLP Investigate Independent Contractor Misclassification in the State of Massachusetts Following the Recent Fedex Decision
4. Massachusetts Communities Receive Grants to Increase Safety for Cycling Groups – Kiley Law Group, LLC
5. BigToys Awarded Prestigious FAC79 Statewide Contract for Massachusetts
6. Kiley Law Group, LLC Releases Massachusetts Motorcycle Safety Checklist
7. Atlantic Information Services’s Medicare Advantage News Reports on Plan Drop-Outs from Massachusetts Dual-Eligibles Demo
8. Fresh Healthy Vending Thrives on the South Coast of Massachusetts
9. Advisory: Is it Time to Move Your Data Center Operations to RI? Is Massachusetts going to put a big tax on big data?
10. Public healths role in health care reform -- Lessons from Massachusetts
11. Distracted Driving Focus Shifts to Drunk Texting Following Recent Massachusetts Collision with Injuries – Kiley Law Group, LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... Yardley, PA (PRWEB) , ... March 23, 2017 ... ... received Patient Oriented Disease Management Accreditation from the NCQA. The accreditation covers StayWell’s ... programs. , Accredited status is granted to organizations that have excellent programs ...
(Date:3/23/2017)... ... , ... The TouchPoint Solution, home of Buzzies *, is boosting the ... , “Buzzies change the way we interact with stress and live our day-to-day lives,” ... date in December 2016, The TouchPoint Solution has sold more than $750,000 in product ...
(Date:3/23/2017)... , ... March 23, 2017 , ... After raising more ... FaceCradle , the most-funded travel pillow in crowdfunding history, has established a ... its wildly popular travel innovation to Americans. , “We’re excited to be operating on ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... today announced rapid completion of the strategic executive team expansion needed to further ... to the ChenMed executive team,” says Christopher Chen, MD, ChenMed Chief Executive Officer. ...
(Date:3/23/2017)... ... March 23, 2017 , ... Natural Subsistence, ... aspects of people’s health and nutrition, announced its product Leyzene is now available ... Subsistence develops nutritional supplements that help people improve all aspects of their health ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... MUMBAI , March 23, 2017 ... de Piramal Enterprises Limited, anuncia el nombramiento de ... PPS ofrece una plataforma de servicios integrados completa ... Needleman desempeñará un cargo clave en el crecimiento ... comercial, Needleman será responsable de impulsar todas las ...
(Date:3/23/2017)... 23, 2017  Galmed Pharmaceuticals Ltd. (Nasdaq: ... clinical-stage biopharmaceutical company focused on the development of ... nonalcoholic steatohepatitis, or NASH, and other liver diseases, ... twelve months ended December 31, 2016, and announced new ... demonstrating Aramchol™,s potential direct effect on liver fibrosis. ...
(Date:3/23/2017)... 23, 2017 ReNeuron reported in December ... in chronic stroke patients, despite not meeting the three-month time ... the Action Research Arm Test (ARAT). As a result, the ... controlled clinical study in 2017. Beyond CTX, we expect safety ... 2017 and Phase I data from its critical limb ischaemia ...
Breaking Medicine Technology: